Skip to content
‹ Back to IndustriesHealthcare

M&A Healthcare Advisors (MAHA) Exclusively Represents On My Care Home Health in their Sale to Excelin Health

M&A Healthcare Advisors (MAHA), a newly founded boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of On My Care Home Health, a large Home Health agency providing skilled nursing, physical, occupational, and speech therapy, as well as social worker and home aide services. Located in the San Francisco Bay area,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
M&A Healthcare Advisors (MAHA) Exclusively Represents On My Care Home Health in their Sale to Excelin Health

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

M&A Healthcare Advisors (MAHA), a newly founded boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of On My Care Home Health, a large Home Health agency providing skilled nursing, physical, occupational, and speech therapy, as well as social worker and home aide services. Located in the San Francisco Bay area, On My Care was acquired by Excelin Health, a portfolio company of Corinthian Equity Fund II, L.P.

“We are excited to add On My Care to our larger portfolio and continue their tradition of excellence. Andre Ulloa and his team at M&A Healthcare Advisors went above and beyond to shepherd this transaction through closing and were integral to getting the deal done. Andre was the consummate intermediary: attentive, responsive, and consistent throughout the entire process.” – Maureen Spivack, President of MAS Advisory Services, LLC and Board Member of Excelin Health.

While the current M&A market has shown signs of slowing down in recent months, with the right support and guidance, transactions are still occurring. The M&A Healthcare Advisors team was able to create increased value for On My Care, successfully navigate through every phase of the sale process, and identify a buyer with unique synergies who would continue building upon their legacy.

“We regularly speak about how our involvement directly increases the probability of a company being sold and drives the enterprise value of the businesses we represent. The sale process for On My Care Home Health is a direct testament to those principles, our experience, and Andre’s remarkable daily effort to ensure the best outcome for our client”, say Co-Founders Mike Moran & Mark Thomas

This success proves the effectiveness of M&A Healthcare Advisors’ approach only 8 months after their founding.

“The team at M&A Healthcare Advisors [MAHA] was the perfect complement for us as a seller. They matched my work ethic and quick responsiveness. They were supportive, taking on all sale’s process tasks which did not require my involvement, allowing me to focus on my operations.

Although the tangible work product was excellent, what was most impressive to me was their technical consistency and emotional fortitude through a very arduous due diligence process. There were many evenings we would spend on the phone assessing that day’s events and adjusting our approach for the days to come. MAHA introduced me to our transactional attorneys, as well; all the while working side-by-side with the legal team to ensure that every aspect of the purchase agreement was as good as it could be.

In the end, after an eight-month process, all parties walked away with a mutually beneficial deal. I thank that, in large part, to the efforts of MAHA.” – Hans Gill, CEO of On My Care Home Health

About M&A Healthcare Advisors

M&A Healthcare Advisors (MAHA), is a boutique merger and acquisition (M&A) advisory group, focused on the lower-middle market healthcare industry. Our core purpose is to provide comprehensive, efficient, and committed transactional support for emerging or established, lower-middle market healthcare businesses. Our team is highly accessible, experienced, process-driven, and seeks to bring a superior level of guidance to every engagement. We relentlessly advocate for our clients, constantly reinforcing the most essential value: TRUST.

With over 50 successful healthcare transactions in the past five years, the team at M&A Healthcare Advisors has sold companies in a variety of healthcare segments: Behavioral Health, Autism, I/DD, Hospice, Home Health, Home Care, Private Duty, Physical Therapy, Staffing/Medical Recruiting, Not-for-Profits and all types of Pharmacy. Their full suite of services includes Sell-Side Representation, M&A Hourly Consulting, and Expert Valuation services.

Business Contact

Mark Thomas

Partner, Director of Operations

M&A Healthcare Advisors

mthomas@mahealthcareadvisors.com

Media Contact

Matt Santoro

matt@elkordyglobal.com

SOURCE M&A Healthcare Advisors

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's PressSure is a battery-powered device that holds standard pressure bags at one of three fixed preset pressures during blood or IV fluid infusions.

  • 01So far it’s manufacturer design claims; what matters next is in-service reports from early hospital or EMS adopters.

Oct 1, 2026

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

On I Don’t Care, BedConnect founder Lindsey Joseph and Kevin Stevenson discuss the limits of broad post-acute referrals. Their proposal is to match clinical needs, payer coverage and available beds before presenting options. CMS guidance and AHRQ discharge resources provide independent context; they do not establish BedConnect’s clinical outcomes.

  • 01BedConnect proposes matching clinical needs, payer coverage and bed availability before presenting post-acute options; this is the company’s approach, not independently validated outcome evidence.
  • 02CMS discharge-planning guidance emphasizes patient goals, treatment preferences and relevant provider quality and resource-use data.
  • 03Readmission comparisons need a defined patient group, time window and source; the interview’s roughly one-quarter/fourteen-day estimate has not been independently verified.

Sep 29, 2026

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: U.S. digital health startups raised $7.4 billion across 244 deals in H1 2026, up from $6.4 billion on 245 deals in H1 2025. The rebound is concentrated. Nineteen companies raised 20 $100 million-plus rounds that captured 45% of capital.

  • 01In H1 2026, 19 companies raised 20 mega-deals of $100 million or more, representing 45% of all capital invested, according to Rock Health.
  • 02According to Rock Health, the firm stopped labeling startups as “AI-enabled,” saying the technology is now too widespread for the label to be meaningful.

Sep 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512